Further, the CVOTs in general also suggested a potential benefit of GLP-1 RAs on HF, positioning GLP-1 RAs as another advanced option alongside SGLT2 inhibitors in the otherwise sparse treatment armamentarium for especially HFpEF
Regular follow-up, individualized dosing, and ongoing clinical monitoring are important parts of physician-guided treatment
P = .001), but no difference was observed between the combined therapy and semaglutide groups
Liraglutide weight loss clinical trials Semaglutide is another GLP-1 product developed by Novo Nordisk with a better weight loss effect than liraglutide
So if you're going to go off the medication, you're likely to struggle because of metabolic adaptation, but this is how you actually fight back to the best of your ability by adopting these new behaviors
Changes in blood pressure may also occur as patients lose weight or experience fluid shifts during early treatment